Physician profile
Matthew Smith
NPI 1588688543
$6,373.17
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,526 · 2020: $1,452 · 2021: $1,288 · 2022: $1,107.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,796.22 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $1,482.36 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $685.35 | 2019-2022 | |
| Mylan Specialty L.P. | $553.59 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $286.17 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $224.70 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $211.07 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $204.06 | 2019-2022 | |
| United Therapeutics Corporation | $137.65 | 2019-2021 | |
| Genentech USA, INC. | $112.19 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $96.73 | 2019-2022 | |
| Amgen INC. | $86.29 | 2021-2022 | |
| Harmony Biosciences LLC | $65.06 | 2020 | |
| Vapotherm INC | $64.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.90 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $58.95 | 2019-2022 | |
| Insmed, INC. | $57.61 | 2019-2022 | |
| Covis Pharma Gmbh | $48.89 | 2022 | |
| Eisai INC. | $44.69 | 2021-2022 | |
| Baxter Healthcare | $43.67 | 2022 | |
| Inogen, INC. | $22.65 | 2022 | |
| Nabriva Therapeutics, Plc | $12.93 | 2020 | |
| Circassia INC. | $12.48 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.